Connect with us

Life Sciences

United States Precision Medicine Business Investment Opportunities Report 2023: Unlocking the Potential – Market to Surpass $43 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United States Precision Medicine Business Investment Opportunities Databook – Q2 2023 Update” report…
The post…

Published

on

This article was originally published by IT Business Net

DUBLIN–(BUSINESS WIRE)–The “United States Precision Medicine Business Investment Opportunities Databook – Q2 2023 Update” report has been added to ResearchAndMarkets.com’s offering.


United States’ precision medicine market size is expected to record a CAGR of 13.2% during 2023-2027 to reach US$43.19 billion by 2027, increasing from US$26.283 billion in 2023. Over the last five years, the sector has recorded a CAGR of 12.9% to reach US$23.274 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the precision medicine industry. It covers a detailed view of market size and forecast across various segments such as by category, technology platform, by technology, by gene sequencing technology, by drugs, by route of administration, by application, and by end-users.

Reasons to Buy

  • In-depth understanding of precision medicine market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in United States.
  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
  • Get market share analysis by end-users: Get a detailed analysis across different end-users such as pharmaceuticals and biotechnology companies, diagnostics companies, healthcare IT specialists/big data companies, clinical laboratories within the United States.

Report Scope

Precision medicine market share by category

  • Diagnostics
  • Therapeutics
  • Others

Precision medicine market share by technology platform

  • Cloud Based
  • On-Premises

Precision medicine market share by technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Companion Diagnostics
  • Gene Sequencing
  • Others

Precision medicine market share by sequencing technology

  • Chain Termination Sequencing
  • Nanopore Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Ion Semiconductor Sequencing
  • Single Molecule Real Time Sequencing
  • Sequencing by Synthesis

Precision medicine market share by drugs

  • Mepolizumab
  • Osimertinib
  • Aripiprazole Lauroxil
  • Alectinib
  • Others

Precision medicine market share by route of administration

  • Injectable
  • Oral
  • Others

Precision medicine market share by application

  • Oncology
  • CNS
  • Cardiovascular
  • Infectious Diseases
  • Others

Precision medicine market share by end-user

  • Pharmaceuticals and Biotechnology Companies
  • Diagnostics Companies
  • Healthcare IT Specialists/Big Data Companies
  • Clinical Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/w1qpxr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

The post United States Precision Medicine Business Investment Opportunities Report 2023: Unlocking the Potential – Market to Surpass $43 Billion by 2027 – ResearchAndMarkets.com first appeared on IT Business Net.
bioinformatics


pharmaceuticals

big data
data analytics

markets

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending